---
author: Harvey Guo
created: 2023-08-31 13:56
modified: 2023-08-31 13:56
aliases: Sickle cell anemia
share: true
---
# Epidemiology


---
# Etiology


---
# Pathophysiology


---
# Clinical features


---
# Diagnostics


---
# Treatment
## Overview
### Infants and children
- Antibiotic prophylaxis against invasive pneumococcal disease until 5 years of age
- <span style="background:rgba(240, 200, 0, 0.2)">Hydroxyurea therapy</span> regardless of clinical severity to minimize disease-related complications **(First-line)**
- Annual transcranial doppler to screen for stroke risk from 2 months till 16 years of age
### Hydroxyurea therapy
#### Indications
- All infants > 9 months, children, and adolescents with sickle cell anemia regardless of symptom severity 
- Adults with any of the following:
	- Frequent (â‰¥ 3 episodes/year) acute pain episodes or other vasoocclusive events
	- Severe symptomatic anemia
	- History of severe and/or recurrent acute chest syndrome
#### Mechanism of action
Stimulation of erythropoiesis and increased fetal hemoglobin

---
